Table 1.
Patients characteristics of all patients, with ARDS due to COVID-19, which underwent LUS, Wells score and CTPA: the number within the two groups (PE vs. non-PE) as well as the percentage in relation to the entire group or the standard deviation are given
| Characteristics | With PE | No PE | p value < 0.05* |
|---|---|---|---|
| Number | 12.0 (60%) | 8.0 (40%) | 0.690 |
| Age | 59.0 ± 8.0 | 65.5 ± 11.8 | 0.190 |
| Female | 4.0 (20.0%) | 2.0 (10.0%) | 0.690 |
| BMI (kg/m2) | 26.9 ± 3.6 | 30.4 ± 8.8 | 0.285 |
| ICU-mortality | 5.0 (25%) | 4.0 (20%) | 0.713 |
| ICU-stay (in days) | 27.3 ± 26.8 | 30.0 ± 23.3 | 0.819 |
| TISS 10—score | 17.0 ± 6.7 | 15.4 ± 5.8 | 0.500 |
| SAPS 2—score | 50.0 ± 10.4 | 45.9 ± 15.4 | 0.395 |
| d-dimers (mg/l) (at time of LUS) | 16.3 ± 13.3 | 13.5 ± 12.6 | 0.579 |
| d-dimers (mg/l) (at time of admission) | 6.7 ± 6.0 | 4.2 ± 3.0 | 0.526 |
| Wells score (at time of LUS) | 2.7 ± 0.8 | 1.7 ± 0.5 | 0.042 |
| Therapeutic anticoagulation (at time of admission) | 1.0 (5.0%) | 4.0 (20.0%) | 0.035 |
| Echocardiography: PAP sys (mmHg) | 46.8 ± 18.9 | 42.6 ± 16.0 | 0.563 |
| Invasive mechanical respiratory support (in days) | 28.8 ± 29.4 | 29.1 ± 25.0 | 0.988 |
| On ECMO support | 7 (35%) | 4 (20%) | 0.713 |
| Pre-existing co-morbidities | |||
| Lung disorder | 1.0 (5.0%) | 4.0 (20.0%) | 0.035 |
| Tobacco smoke | 3.0 (15.0%) | 5.0 (25.0%) | 0.094 |
| Diabetes mellitus | 3.0 (15.0%) | 0.0 (0.0%) | 0.125 |
| Arterial hypertension | 3.0 (15.0%) | 4.0 (20.0%) | 0.251 |
| Heart failure | 2.0 (10.0%) | 3.0 (15.0%) | 0.292 |
| Kidney failure | 1.0 (0.5%) | 1.0 (5.0%) | 0.761 |
| Liver failure | 0.0 (0.0%) | 1.0 (5.0%) | 0.210 |
| Coagulopathy | 1.0 (5.0%) | 0.0 (0.0%) | 0.402 |
| Immunodeficiency | 3.0 (15.0%) | 0.0 (0.0%) | 0.125 |
| Obesity (BMI > 30) | 2.0 (10.0%) | 2.0 (10.0%) | 0.648 |
Significant values are given in bold (p < 0.05)